AJCN Tufts Nutrition Symposium, Boston Sept 24-26
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BAKER, E. M.
Right arrow Articles by MARCH, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BAKER, E. M.
Right arrow Articles by MARCH, S. C.
Agricola
Right arrow Articles by BAKER, E. M.
Right arrow Articles by MARCH, S. C.

American Journal of Clinical Nutrition, Vol 22, 549-558, Copyright © 1969 by The American Society for Clinical Nutrition, Inc.

Metabolism of Ascorbic-1-14C Acid in Experimental Human Scurvy

EUGENE M. BAKER PH.D.1, ROBERT E. HODGES M.D.1, JAMES HOOD M.D.1, HOWERDE E. SAUBERLICH PH.D.1, and STEVEN C. MARCH B.A.1

1 From the Chemistry Division, U.S. Army Medical Research and Nutrition Laboratory, Fitzsimons General Hospital, Denver, Colorado, and the Department of Internal Medicine, University Hospitals, University of Iowa, Iowa City, Iowa

A study of the metabolism of ascorbic-l-14C acid in experimental human scurvy was conducted with the following results:

1) Labeling the body ascorbic acid pool during the depletion phase resulted in no detectable urinary excretion of 14C-labeled reduced ascorbic acid or dehydroascorbic acid.

2) Urinary excretion of 14C by all subjects occurred as a first order process during the depletion phase. The urinary 14C excretion curves of the four subjects did not differ from the average man by more than ± 3%, despite marked differences in body weight and age.

3) First symptoms of mild scurvy appeared in the subjects when their body ascorbic acid pool had been reduced to approximately 300 mg.

4) Once the body pool of ascorbic acid was repleted to a level of 1.5 g, urinary loss of reduced ascorbic acid occurred.

5) The rate of repletion of ascorbic acid was found to be a zero-order process and proportional to the level of daily ascorbic acid intake.

6) When the subjects were fed a high intake of ascorbic acid, only a limited quantity of the ingested vitamin was equilibrated with the 14C-labeled ascorbate pool.

7) All of the radioactivity excreted during the depletion phase was in the form of stable organic material that did not behave as ascorbic acid. This organic material was separated into four unknown compounds.

8) The daily intake of 6.5 mg/day of ascorbic acid was sufficient to alleviate and cure the clinical signs of scurvy in one man.




This article has been cited by other articles:


Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
J. W. Lampe
Nutrition and Cancer Prevention: Small-scale Human Studies for the 21st Century
Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 1987 - 1988.
[Full Text] [PDF]

Home page
 J. Am. Coll. Nutr.Home page
G. Block, A. R. Mangels, B. H. Patterson, O. A. Levander, E. P. Norkus, and P. R. Taylor
Body Weight and Prior Depletion Affect Plasma Ascorbate Levels Attained on Identical Vitamin C Intake: A Controlled-Diet Study
J. Am. Coll. Nutr., December 1, 1999; 18(6): 628 - 637.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
E. M. Baker III, D. C. Hammer, S. C. March, B. M. Tolbert, and J. E. Canham
Ascorbate Sulfate: A Urinary Metabolite of Ascorbic Acid in Man
Science, August 27, 1971; 173(3999): 826 - 827.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1969 by The American Society for Nutrition